Cargando…

Combination value of diffusion-weighted imaging and dynamic susceptibility contrast-enhanced MRI in astrocytoma grading and correlation with GFAP, Topoisomerase IIα and MGMT

The present study aimed to investigate the value of diffusion-weighted imaging (DWI) combined with dynamic susceptibility contrast-enhanced (DSC) magnetic resonance imaging (MRI) scans in astrocytoma grading, and correlated MRI scan parameters of values of apparent diffusion coefficient (ADC) and re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qin, Jiang-Bo, Zhang, Hui, Wang, Xiao-Chun, Tan, Yan, Wu, Xiao-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704283/ https://www.ncbi.nlm.nih.gov/pubmed/31452754 http://dx.doi.org/10.3892/ol.2019.10656

Ejemplares similares

Diffusion Kurtosis Imaging Reflects Glial Fibrillary Acidic Protein (GFAP), Topo IIα, and O(6)-Methylguanine-DNA Methyltransferase (MGMT) Expression in Astrocytomas
por: Wang, Xiao-chun, et al.
Publicado: (2018)

Differentiation of pilocytic astrocytoma, medulloblastoma, and hemangioblastoma on diffusion-weighted and dynamic susceptibility contrast perfusion MRI
por: Kurokawa, Ryo, et al.
Publicado: (2022)

GFAP expression is influenced by astrocytoma grade and rs2070935 polymorphism
por: Sereika, Mantas, et al.
Publicado: (2018)

Grading of IDH-mutant astrocytoma using diffusion, susceptibility and perfusion-weighted imaging
por: Yang, Xiefeng, et al.
Publicado: (2022)

GFAPδ/GFAPα ratio directs astrocytoma gene expression towards a more malignant profile
por: Stassen, Oscar M.J.A., et al.
Publicado: (2017)

Importance of GFAP isoform‐specific analyses in astrocytoma
por: van Bodegraven, Emma J., et al.
Publicado: (2019)

Diffuse GFAP Immunopositivity in the Oligodendrocyte-like Component of Pilocytic Astrocytoma Distinguishes It from Mimickers
por: Alturkustani, Murad
Publicado: (2022)

Association Between CD204-Expressed Tumor-Associated Macrophages and MGMT-Promoter Methylation in the Microenvironment of Grade 4 Astrocytomas
por: Kurdi, Maher, et al.
Publicado: (2022)

An MRI-based joint model of radiomics and spatial distribution differentiates autoimmune encephalitis from low-grade diffuse astrocytoma
por: Piao, Sirong, et al.
Publicado: (2022)

Diffusion differences between pilocytic astrocytomas and grade II ependymomas
por: Pavlisa, Goran, et al.
Publicado: (2011)

A multi-sequence and habitat-based MRI radiomics signature for preoperative prediction of MGMT promoter methylation in astrocytomas with prognostic implication
por: Wei, Jingwei, et al.
Publicado: (2018)

Extent, pattern, and prognostic value of MGMT promotor methylation: does it differ between glioblastoma and IDH-wildtype/TERT-mutated astrocytoma?
por: Teske, Nico, et al.
Publicado: (2021)

Magnetic Resonance Spectroscopy for Prediction of Grades of Diffusely Infiltrating Intracranial Astrocytomas
por: Abu, Obaida, et al.
Publicado: (2020)

Extent and prognostic value of MGMT promotor methylation in glioma WHO grade II
por: Karschnia, Philipp, et al.
Publicado: (2020)

Accuracies and Contrasts of Models of the Diffusion-Weighted-Dependent Attenuation of the MRI Signal at Intermediate b-values
por: Nicolas, Renaud, et al.
Publicado: (2015)

Immunohistochemical Expression of PD-L1 and IDH1 with Detection of MGMT Promoter Methylation in Astrocytoma
por: Hareedy, Amal Ahmed, et al.
Publicado: (2022)

Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging
por: Li, Xiaoguang, et al.
Publicado: (2015)

Systemic Metastasis of Pediatric Diffuse High-grade Astrocytoma: A Case Report
por: CHIBA, Kentaro, et al.
Publicado: (2023)

Dynamic susceptibility contrast perfusion-weighted and diffusion-weighted magnetic resonance imaging findings in pilocytic astrocytoma and H3.3 and H3.1 variant diffuse midline glioma, H3K27-altered
por: Kurokawa, Ryo, et al.
Publicado: (2023)

IDH mutant and 1p/19q co-deleted oligodendrogliomas: tumor grade stratification using diffusion-, susceptibility-, and perfusion-weighted MRI
por: Lin, Yu, et al.
Publicado: (2017)

Diagnostic value of diffusion-weighted imaging with synthetic b-values in breast tumors: comparison with dynamic contrast-enhanced and multiparametric MRI
por: Daimiel Naranjo, Isaac, et al.
Publicado: (2020)

MGMT promoter hypermethylation is a frequent, early, and consistent event in astrocytoma progression, and not correlated with TP53 mutation
por: Groenendijk, Floris H., et al.
Publicado: (2010)

Promoter methylation of RB1, P15, P16, and MGMT and their impact on the clinical course of pilocytic astrocytomas
por: Sippl, Christoph, et al.
Publicado: (2018)

Astrocytic tumour grading: a comparative study of three-dimensional pseudocontinuous arterial spin labelling, dynamic susceptibility contrast-enhanced perfusion-weighted imaging, and diffusion-weighted imaging
por: Xiao, Hua-Feng, et al.
Publicado: (2015)

The Significance of MGMT Promoter Methylation Status in Diffuse Glioma
por: Jovanović, Nikola, et al.
Publicado: (2022)

Diffusion-weighted imaging in relation to morphology on dynamic contrast enhancement MRI: the diagnostic value of characterizing non-puerperal mastitis
por: Zhang, Lina, et al.
Publicado: (2017)

5-hydroxymethylcytosine loss is associated with poor prognosis for patients with WHO grade II diffuse astrocytomas
por: Zhang, Feng, et al.
Publicado: (2016)

Value of MRI and diffusion-weighted MRI for the diagnosis of locally recurrent rectal cancer
por: Lambregts, Doenja M. J., et al.
Publicado: (2011)

Diagnostic accuracy of diffusion weighted imaging for differentiation of supratentorial pilocytic astrocytoma and pleomorphic xanthoastrocytoma
por: She, Dejun, et al.
Publicado: (2018)

Diffusion Weighted MRI for Hepatic Fibrosis: Impact of b-Value
por: Ozkurt, Huseyin, et al.
Publicado: (2014)

Intracranial paragangliomas versus schwannomas: Role of dynamic susceptibility contrast perfusion and diffusion MRI
por: Ota, Yoshiaki, et al.
Publicado: (2022)

GFAP at 50
por: Messing, Albee, et al.
Publicado: (2020)

Differentiation of various salivary gland tumours using diffusion-weighted MRI and dynamic contrast-enhanced MRI
por: Kushwaha, Mohini, et al.
Publicado: (2023)

Value of Perfusion Weighted Magnetic Resonance Imaging in the Diagnosis of Supratentorial Anaplastic Astrocytoma
por: Lee, Kyung Mi, et al.
Publicado: (2014)

GFAP Alternative Splicing and the Relevance for Disease – A Focus on Diffuse Gliomas
por: van Asperen, Jessy V., et al.
Publicado: (2022)

Microsomal membrane proteome of low grade diffuse astrocytomas: Differentially expressed proteins and candidate surveillance biomarkers
por: Polisetty, Ravindra Varma, et al.
Publicado: (2016)

Synthetic Apparent Diffusion Coefficient for High b-Value Diffusion-Weighted MRI in Prostate
por: Sahoo, Prativa, et al.
Publicado: (2020)

Molecular Landscape for Malignant Transformation in Diffuse Astrocytoma
por: Tunthanathip, Thara, et al.
Publicado: (2021)

Diffusion-weighted MRI for detecting liver metastases: importance of the b-value
por: Kwee, Thomas C., et al.
Publicado: (2010)

Testicular tumors: discriminative value of conventional MRI and diffusion weighted imaging
por: Wang, Weiwei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h8nggb35hfb1vpe4pfnbjqlkvm